Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22


Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.

Wilkins HM, Weidling IW, Ji Y, Swerdlow RH.

Front Immunol. 2017 Apr 26;8:508. doi: 10.3389/fimmu.2017.00508. eCollection 2017. Review.


New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Wilkins HM, Morris JK.

Curr Pharm Des. 2017;23(5):731-752. doi: 10.2174/1381612822666161230144517.


Bioenergetics and metabolism: a bench to bedside perspective.

Swerdlow RH.

J Neurochem. 2016 Oct;139 Suppl 2:126-135. doi: 10.1111/jnc.13509. Epub 2016 Mar 10. Review.


Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies.

Wilkins HM, Carl SM, Swerdlow RH.

Redox Biol. 2014;2:619-31. doi: 10.1016/j.redox.2014.03.006. Epub 2014 Apr 1. Review.


A fruitful endeavor: modeling ALS in the fruit fly.

Casci I, Pandey UB.

Brain Res. 2015 May 14;1607:47-74. doi: 10.1016/j.brainres.2014.09.064. Epub 2014 Oct 5. Review.


Sirtuins as therapeutic targets of ALS.

Pasinetti GM, Bilski AE, Zhao W.

Cell Res. 2013 Sep;23(9):1073-4. doi: 10.1038/cr.2013.94. Epub 2013 Jul 16.


The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Redler RL, Dokholyan NV.

Prog Mol Biol Transl Sci. 2012;107:215-62. doi: 10.1016/B978-0-12-385883-2.00002-3. Review.


Mitochondria in neurodegeneration.

Lezi E, Swerdlow RH.

Adv Exp Med Biol. 2012;942:269-86. doi: 10.1007/978-94-007-2869-1_12. Review.


Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency.

Alavian KN, Dworetzky SI, Bonanni L, Zhang P, Sacchetti S, Mariggio MA, Onofrj M, Thomas A, Li H, Mangold JE, Signore AP, Demarco U, Demady DR, Nabili P, Lazrove E, Smith PJ, Gribkoff VK, Jonas EA.

Brain Res. 2012 Mar 29;1446:1-11. doi: 10.1016/j.brainres.2012.01.046. Epub 2012 Jan 28.


Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.

Swerdlow RH.

Pharmaceuticals (Basel). 2009 Dec 3;2(3):150-167.


Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis.

Zhao W, Varghese M, Yemul S, Pan Y, Cheng A, Marano P, Hassan S, Vempati P, Chen F, Qian X, Pasinetti GM.

Mol Neurodegener. 2011 Jul 19;6(1):51. doi: 10.1186/1750-1326-6-51.


Mitochondria as a therapeutic target for aging and neurodegenerative diseases.

Reddy PH, Reddy TP.

Curr Alzheimer Res. 2011 Jun;8(4):393-409. Review.


Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.

Carvalho C, Correia SC, Santos RX, Cardoso S, Moreira PI, Clark TA, Zhu X, Smith MA, Perry G.

J Bioenerg Biomembr. 2009 Oct;41(5):433-40. doi: 10.1007/s10863-009-9247-1. Review.


The neurodegenerative mitochondriopathies.

Swerdlow RH.

J Alzheimers Dis. 2009;17(4):737-51. doi: 10.3233/JAD-2009-1095. Review.


Calcium signaling in neurodegeneration.

Marambaud P, Dreses-Werringloer U, Vingtdeux V.

Mol Neurodegener. 2009 May 6;4:20. doi: 10.1186/1750-1326-4-20.


Mitochondrial DNA sequence variation and neurodegeneration.

Mancuso M, Filosto M, Orsucci D, Siciliano G.

Hum Genomics. 2008 Sep;3(1):71-8. Review.


Mitochondrial DNA damage and repair in neurodegenerative disorders.

Yang JL, Weissman L, Bohr VA, Mattson MP.

DNA Repair (Amst). 2008 Jul 1;7(7):1110-20. doi: 10.1016/j.dnarep.2008.03.012. Epub 2008 May 7. Review.


TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD?

Hermosura MC, Garruto RM.

Biochim Biophys Acta. 2007 Aug;1772(8):822-35. Epub 2007 Feb 24. Review.

Supplemental Content

Support Center